Condition
Microsatellite-stable Colorectal Cancer
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Suspended1
Withdrawn1
Clinical Trials (2)
Showing 2 of 2 trials
NCT07011550Phase 2SuspendedPrimary
Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer
NCT04145193Phase 2WithdrawnPrimary
Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC
Showing all 2 trials